It’s important to tell your care team about side effects right away, if you:
Your experience may vary. If you experience any of the following symptoms of side effects, tell your doctor right away.
Use a treatment journal to document how you're feeling throughout treatment. You can download the journal here.
-related reactions are common but can be severe or serious and can include life-threatening (anaphylaxis) allergic reaction. Most occur during the first infusion.
Tell your doctor right away if you experience:
If you experience an infusion-related reaction: Your treatment team may adjust or pause your infusion dosing and timing to help manage the reaction.
RYBREVANT® may cause lung problems that may lead to death. Symptoms of lung problems may be similar to those from your lung cancer.
Tell your doctor right away if you experience any new or worsening lung symptoms, including:
When RYBREVANT® is given in combination with LAZCLUZE™, blood clots are a serious but common side effect. This can occur in the veins of your legs or lungs.
Tell your doctor right away if you experience:
To help prevent blood clots: Your doctor will start you on a medicine for the first 4 months of treatment.
You may experience severe rash.
Tell your doctor right away if you experience:
If you experience skin problems: Your doctor may treat you with a medicine(s) or send you to see a skin specialist (dermatologist).
What you can do: Taking certain steps can help lower your risk of skin-related side effects. Learn more here. Or, click here for a downloadable guide of tips and reminders to help throughout treatment.
You may experience eye problems.
Tell your doctor right away if you experience:
If you experience eye problems: Your doctor may send you to see an eye specialist (ophthalmologist).
What you can do: You should not use contact lenses until your eye symptoms are checked by a doctor.
RYBREVANT® + LAZCLUZE™ can harm your unborn baby.
Tell your doctor right away if you become pregnant or think you might be pregnant.
What you can do: If you are able to become pregnant, you should use effective birth control during treatment and for 3 months after your final
dose of RYBREVANT®, and during treatment and for 3 weeks after your last dose of LAZCLUZE™.
Your care team can help prevent or manage side effects to help you stay on treatment.
*Mutations include exon 19 deletion or exon 21 L858R substitution mutations.
EGFR+ = mutated epidermal growth factor receptor; NSCLC = non–small cell lung cancer
Once prescribed a RYBREVANT®-based treatment, connect with a Care Navigator for your support needs.